Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and ...

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the ...

Overall, rates of new cancer diagnoses and cancer-related deaths have declined, according to the annual cancer statistics ...

You could have a tumor that starts out 1-10% [ER expression] and you eliminate the ER clones with chemotherapy, and what ...

A new drug that reduces the risk of breast cancer recurrence has been approved in England. According to an analysis by the ...

New research uncovers key factors driving survival and treatment response in patients with HER2-positive breast cancer ...

A case-control study in Iranian women found that higher adherence to a healthy plant-based diet significantly reduces breast ...

BriaCell confirms complete resolution of lung metastasis at 4 months in Phase 1/2a trial using Bria-OTS immunotherapy in ...

A new twice-daily pill has been approved for NHS use, offering a significant reduction in the risk of certain breast cancers ...

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...